Clinical trial
Placebo Controlled Study of Rosiglitazone in HIV Lipoatrophy
NCT00367744 is registered in ClinicalTrials.gov with National Institute of Allergy and Infectious Diseases (NIAID) as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Placebo Controlled Study of Rosiglitazone in HIV Lipoatrophy
- Lead sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- July 31, 2006
- Completion date
- December 31, 2008
- Enrollment
- 71 (actual)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.